Sector Gamma AS lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 24.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,000 shares of the company’s stock after selling 29,098 shares during the period. Cardinal Health accounts for approximately 3.6% of Sector Gamma AS’s portfolio, making the stock its 11th largest position. Sector Gamma AS’s holdings in Cardinal Health were worth $10,408,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Promus Capital LLC purchased a new stake in Cardinal Health in the fourth quarter valued at $30,000. Lee Danner & Bass Inc. purchased a new stake in Cardinal Health in the fourth quarter valued at $35,000. Kentucky Trust Co purchased a new stake in Cardinal Health in the fourth quarter valued at $41,000. HHM Wealth Advisors LLC lifted its position in Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after acquiring an additional 144 shares during the last quarter. Finally, Raleigh Capital Management Inc. lifted its position in Cardinal Health by 29.6% in the fourth quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after acquiring an additional 106 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on CAH. Argus set a $148.00 target price on shares of Cardinal Health in a report on Tuesday, February 4th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $132.00 to $145.00 in a report on Monday, January 6th. Citigroup upped their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. Finally, TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $139.36.
Cardinal Health Trading Up 0.7 %
Shares of CAH opened at $133.02 on Friday. The firm’s 50-day moving average is $127.15 and its two-hundred day moving average is $119.87. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $133.77. The firm has a market capitalization of $32.13 billion, a P/E ratio of 24.82, a PEG ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.52%. Cardinal Health’s dividend payout ratio is presently 37.69%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- How to Start Investing in Real Estate
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Stock Average Calculator
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Basic Materials Stocks Investing
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.